Walgreens joins what has now become a pharmacy trifecta to stop selling Zantac heartburn medicine and its generic versions from store shelves.
Walgreens joins Rite Aid and CVS after the Food and Drug Administration warned this month that it had detected low levels of a cancer-causing chemical in drug samples, according to the New York Times.
Walgreens and CVS announced the move on Saturday.
|WBA||WALGREENS BOOTS ALLIANCE INC.|| 55.31
|CVS||CVS HEALTH CORPORATION||63.07||0.99||+ 1.59%|
|RAD  RITE AID||6.95||-0.33||-4.53%|
The companies said that customers who had purchased the products could return them for a refund.
The FDA looks at the source of the contamination as well as the risk to patients.
CLICK HERE TO READ MORE ON FOX BUSINESS
Zantac, the branded version of the fabric, is sold by Sanofi, but generic versions are sold a lot.